The Latest News and Research Direct to Your Brain

Posts

July 29, 2025

Rocket Science Health Secures U.S Patent for Precision Intranasal Drug Delivery Platform

Author: Rocket Science Health

View

July 21, 2025

Pioneering Precision: New Research Shows Rocket Science Health’s Laminar Fluid Ejection Device Leads in Therapeutic Drug Delivery

Author: Rocket Science Health

View

December 10, 2024

Laminar Fluid Ejection for Olfactory Drug Delivery: A Proof of Concept Study

Author: Rocket Science Health. Published by iEEE.org

View

September 3, 2024

The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters

NIH

View

Previous 1 2

* INVESTIGATIONAL DEVICE NOTICE. Rocket Science Health’s device is an investigational medical device that has not been approved by the U.S. Food and Drug Administration (FDA) for commercial distribution. The device is currently under clinical investigation, and its safety and effectiveness have not been established.

This website is for informational purposes only and is not intended to promote or advertise the device for any specific medical use. The information provided does not constitute medical advice.

July 29, 2025

Rocket Science Health Secures U.S Patent for Precision Intranasal Drug Delivery Platform

Author: Rocket Science Health

View

July 21, 2025

Pioneering Precision: New Research Shows Rocket Science Health’s Laminar Fluid Ejection Device Leads in Therapeutic Drug Delivery

Author: Rocket Science Health

View

December 10, 2024

Laminar Fluid Ejection for Olfactory Drug Delivery: A Proof of Concept Study

Author: Rocket Science Health. Published by iEEE.org

View

September 3, 2024

The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters

NIH

View